These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4970999)

  • 21. [Effect of kanamycin and isoniazid on the sensitivity of Mycobacterium tuberculosis to the defensive factors of the macroorganism].
    Solov'ev VN; Sokolova EM; Chumachenko NV
    Probl Tuberk; 1965; 43(10):69-72. PubMed ID: 4959763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1968 Apr; 13(4):355-9. PubMed ID: 4970747
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 24. [Abnormalities of behavior in vitro of mycobacteria isolated from patients with tuberculosis].
    Cappellato M; Narpozzi A; Pastega G; Torresini G
    G Mal Infett Parassit; 1969 Jan; 21(1):49-75. PubMed ID: 4977162
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of tuberculosis infection and antibacterial preparations on thiamine metabolism].
    Arkhipova OP
    Vopr Med Khim; 1975; 21(5):485-9. PubMed ID: 1216765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK; Miakotina EN; Bellendir EN; Boiarkina SK; Iudelevich VI
    Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibitory effect of amikacin on Mycobacterium tuberculosis in vitro.
    Fodor T
    Acta Microbiol Acad Sci Hung; 1981; 28(4):419-20. PubMed ID: 6797266
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of acridine compounds on stopping the development of drug resistance in Mycobacterium tuberculosis (an experimental study)].
    Efremova IIa; Il'ina TB; Vishnevskiĭ BI; Vavilin GI
    Probl Tuberk; 1977 Sep; (9):61-4. PubMed ID: 411125
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of amikacin on experimental tuberculosis of mice (author's transl)].
    Shimizu T; Yoshida U; Okuyama T
    Kekkaku; 1979 Jan; 54(1):43-9. PubMed ID: 107361
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental research on the antimycobacterial activity of rifampicine: 3-(4-methyl-l-piperazinyl-iminomethyl)-rifomycin SV].
    Lucchesi M; Mancini P; Zubiani M
    Ann Ist Carlo Forlanini; 1967; 27(2):119-36. PubMed ID: 4973676
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the effect of cycloserine and kanamycin on Mycobacterium tuberculosis (bacteriological and electron microscopic study)].
    Chertkova EI
    Probl Tuberk; 1965; 43(9):57-62. PubMed ID: 4958492
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of different combinations of antibacterial preparations on the activity of several enzymes in the tissues of guinea pigs with experimental tuberculosis].
    Izabolinskaia RM; Kruchakova FA; Polner RA
    Vopr Med Khim; 1973; 19(5):462-7. PubMed ID: 4363032
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 40. Amikacin in experimental tuberculosis of guinea pigs.
    Fodor T
    Acta Microbiol Acad Sci Hung; 1982; 29(2):137-8. PubMed ID: 7136862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.